• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH对脆弱拟杆菌群体外抗菌药敏性的影响

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

作者信息

Falagas M E, McDermott L, Snydman D R

机构信息

Department of Pathology (Clinical Microbiology), New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

出版信息

Antimicrob Agents Chemother. 1997 Sep;41(9):2047-9. doi: 10.1128/AAC.41.9.2047.

DOI:10.1128/AAC.41.9.2047
PMID:9303414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC164065/
Abstract

We studied the effect of pH (7.1, 6.3, and 5.8) on the in vitro susceptibilities of 59 isolates of Bacteroides fragilis and 60 isolates of other B. fragilis group species to trovafloxacin, ciprofloxacin, clindamycin, ampicillin-sulbactam, piperacillin-tazobactam, imipenem, and meropenem. For each agent tested the geometric mean MIC was highest at pH 5.8, intermediate at pH 6.3, and lowest at pH 7.1. The magnitude of the pH effect varied greatly among different antibiotics. These data show that an acidic pH decreases the in vitro susceptibilities of the B. fragilis group to several antibiotics.

摘要

我们研究了pH值(7.1、6.3和5.8)对59株脆弱拟杆菌和60株其他脆弱拟杆菌属菌种的体外药敏性的影响,这些菌种对曲伐沙星、环丙沙星、克林霉素、氨苄西林-舒巴坦、哌拉西林-他唑巴坦、亚胺培南和美罗培南的药敏性。对于每种测试药物,几何平均最低抑菌浓度(MIC)在pH 5.8时最高,在pH 6.3时居中,在pH 7.1时最低。pH值影响的程度在不同抗生素之间差异很大。这些数据表明,酸性pH值会降低脆弱拟杆菌属对几种抗生素的体外药敏性。

相似文献

1
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.pH对脆弱拟杆菌群体外抗菌药敏性的影响
Antimicrob Agents Chemother. 1997 Sep;41(9):2047-9. doi: 10.1128/AAC.41.9.2047.
2
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.脆弱拟杆菌群物种及其他厌氧菌对美罗培南、亚胺培南、哌拉西林、头孢西丁、氨苄西林/舒巴坦、克林霉素和甲硝唑的敏感性比较。
J Antimicrob Chemother. 1993 Mar;31(3):363-72. doi: 10.1093/jac/31.3.363.
3
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.脆弱拟杆菌群各菌种对新型β-内酰胺类药物的体外敏感性
J Antimicrob Chemother. 1999 Jan;43(1):133-6. doi: 10.1093/jac/43.1.133.
4
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.克林霉素、亚胺培南、甲硝唑和哌拉西林-他唑巴坦对脆弱拟杆菌敏感和耐药分离株的体外活性评价——通过杀菌动力学。
Antimicrob Agents Chemother. 2012 Jun;56(6):3413-6. doi: 10.1128/AAC.00099-12. Epub 2012 Mar 19.
5
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.2009年至2012年在韩国一家医院分离出的脆弱拟杆菌群生物体临床分离株的抗菌药敏性。
Ann Lab Med. 2015 Jan;35(1):94-8. doi: 10.3343/alm.2015.35.1.94. Epub 2014 Dec 8.
6
Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.新型喹诺酮类药物WIN 57273与哌拉西林加他唑巴坦对厌氧菌的体外比较活性
Antimicrob Agents Chemother. 1990 Sep;34(9):1858-61. doi: 10.1128/AAC.34.9.1858.
7
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.曲伐沙星与环丙沙星、司帕沙星、甲硝唑、头孢西丁、哌拉西林及哌拉西林/他唑巴坦对六种厌氧菌活性的时间-杀菌研究
J Antimicrob Chemother. 1997 Jun;39 Suppl B:23-7. doi: 10.1093/jac/39.suppl_2.23.
8
In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.脆弱拟杆菌群菌种的体外药敏:分离率的变化显著影响总体药敏数据。
J Clin Microbiol. 2002 Nov;40(11):4349-52. doi: 10.1128/JCM.40.11.4349-4352.2002.
9
Susceptibilities of 23 Desulfovibrio isolates from humans.从人类中分离的 23 株脱硫弧菌的药敏试验
Antimicrob Agents Chemother. 2009 Dec;53(12):5308-11. doi: 10.1128/AAC.00630-09. Epub 2009 Sep 28.
10
Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.脆弱拟杆菌群、普雷沃菌属、梭杆菌属、卟啉单胞菌属和消化链球菌属临床分离株体外抗菌药敏变化的多中心调查。
Antimicrob Agents Chemother. 2001 Apr;45(4):1238-43. doi: 10.1128/AAC.45.4.1238-1243.2001.

引用本文的文献

1
pH variation in medical implant biofilms: Causes, measurements, and its implications for antibiotic resistance.医用植入物生物膜中的pH值变化:成因、测量及其对抗生素耐药性的影响
Front Microbiol. 2022 Oct 31;13:1028560. doi: 10.3389/fmicb.2022.1028560. eCollection 2022.
2
Cell density-dependent antibiotic tolerance to inhibition of the elongation machinery requires fully functional PBP1B.细胞密度依赖性抗生素耐药性对伸长机制的抑制作用需要完全功能的 PBP1B。
Commun Biol. 2022 Feb 3;5(1):107. doi: 10.1038/s42003-022-03056-x.
3
In vitro antibacterial activity of nimbolide against Helicobacter pylori.尼莫地尔体外抗幽门螺杆菌活性的研究。
J Ethnopharmacol. 2022 Mar 1;285:114828. doi: 10.1016/j.jep.2021.114828. Epub 2021 Nov 9.
4
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.将驱虫药尼氯硝唑重新用于对抗幽门螺杆菌。
Sci Rep. 2018 Feb 27;8(1):3701. doi: 10.1038/s41598-018-22037-x.
5
Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.一种新型质子载体对耐甲氧西林金黄色葡萄球菌的活性。
Future Med Chem. 2017 Aug;9(12):1401-1411. doi: 10.4155/fmc-2017-0047. Epub 2017 Aug 3.
6
pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.pH调节气道表面液体抗菌剂β-防御素-3和LL-37的活性及协同作用。
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18703-8. doi: 10.1073/pnas.1422091112. Epub 2014 Dec 15.
7
The affect of pH and bacterial phenotypic state on antibiotic efficacy.pH 值和细菌表型状态对抗生素疗效的影响。
Int Wound J. 2012 Aug;9(4):428-35. doi: 10.1111/j.1742-481X.2011.00902.x. Epub 2011 Dec 19.
8
Meropenem: an updated review of its use in the management of intra-abdominal infections.美罗培南:其在腹腔内感染管理中应用的最新综述
Drugs. 2000 Sep;60(3):619-46. doi: 10.2165/00003495-200060030-00010.

本文引用的文献

1
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.1990年至1994年间脆弱拟杆菌群临床分离株抗菌药物耐药模式的趋势分析。
Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65. doi: 10.1093/clinids/23.supplement_1.s54.
2
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.采用棋盘法和时间杀菌法测定头孢匹罗和头孢噻肟单独及与万古霉素和替考拉宁联合使用时的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1996 Sep;40(9):1973-6. doi: 10.1128/AAC.40.9.1973.
3
High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.大剂量头孢噻肟治疗对广谱头孢菌素敏感性降低的成人肺炎链球菌性脑膜炎
Antimicrob Agents Chemother. 1996 Jan;40(1):218-20. doi: 10.1128/AAC.40.1.218.
4
Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France.法国儿童脑膜炎肺炎链球菌菌株中青霉素耐药性传播的机制
J Infect Dis. 1996 Sep;174(3):520-8. doi: 10.1093/infdis/174.3.520.
5
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.耐青霉素肺炎链球菌所致脑膜炎的管理
Antimicrob Agents Chemother. 1995 Oct;39(10):2171-5. doi: 10.1128/AAC.39.10.2171.
6
Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.急性细菌性脑膜炎患儿脑脊液中对耐头孢菌素肺炎链球菌的杀菌活性。
Antimicrob Agents Chemother. 1995 Sep;39(9):1988-92. doi: 10.1128/AAC.39.9.1988.
7
Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.pH、pO2和pCO2的病理变化对体外抗菌剂活性的影响。
Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):519-26. doi: 10.1007/BF01970957.
8
Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections.腹腔液pH值对氨基糖苷类药物治疗腹腔内感染疗效的影响。
World J Surg. 1993 May-Jun;17(3):393-7. doi: 10.1007/BF01658708.
9
[Influence of urine pH and cations on antimicrobial activities of penems].[尿液pH值和阳离子对青霉烯类抗菌活性的影响]
Kansenshogaku Zasshi. 1993 May;67(5):435-9. doi: 10.11150/kansenshogakuzasshi1970.67.435.
10
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.用于治疗实验性耐青霉素和头孢菌素肺炎球菌脑膜炎的抗菌方案评估
Antimicrob Agents Chemother. 1993 Aug;37(8):1630-6. doi: 10.1128/AAC.37.8.1630.